May 7, 2026
ROCHESTER, N.Y. — To help support adoption of myopia management treatments, CooperVision has launched the MiSight 1 day Switch Guarantee. The goal of the program is to smooth patients’ transition from single-vision contact lenses to MiSight 1 day contact lenses.
The initiative is intended to address common barriers to adoption, including cost concerns and hesitation around changing treatment plans. The program provides a lower-risk opportunity for families to try MiSight 1 day, with reimbursement options should they choose to return to the child’s previous single vision contact lenses.
Families can return up to two opened 90-pack boxes of MiSight 1 day for a refund of up to $300 and may also receive reimbursement of up to $200 for repurchasing their child’s previous contact lenses. MiSight 1 day is the only FDA approved soft contact lens clinically proven to slow myopia progression while also correcting vision, reinforcing its role as a proactive treatment option for children with myopia.
More information about the MiSight 1 day Switch Guarantee and available practice tools are available at https://coopervision.com/
Read more of the latest myopia news here

